Impact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment
Launched by FUDAN UNIVERSITY · May 3, 2024
Trial Information
Current as of July 16, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special online tool can help parents in China find correct information about the HPV vaccine and reduce any false beliefs they might have. The study aims to see if this tool, which provides fact-checking information, can help parents make better decisions regarding the HPV vaccination for their middle school daughters.
To participate in this study, you must be a parent or legal guardian of a girl currently attending middle school who has not yet received the HPV vaccine. You also need to be willing to take part in the study and complete the activities without any issues related to mental health or reading. If you join the study, you can expect to engage with the fact-checking tool and share your thoughts on its effectiveness. This research is important because it could help more young girls get vaccinated and protect them from HPV-related health issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants must be parents or legal guardians of female students currently enrolled in participating middle school.
- • 2. The parent's or guardian's female middle school student must not have received the HPV vaccine, must not have an HPV vaccination appointment scheduled, and must not have any contraindications to receiving the HPV vaccine.
- • 3. Participants must be free of mental health disorders or visual/reading disabilities that could prevent their full participation in and completion of the intervention activities.
- • 4. Participants must have provided informed consent and expressed a willingness to actively participate throughout the study.
- • Exclusion criteria are defined as individuals not meeting the aforementioned inclusion criteria.
About Fudan University
Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chizhou, Anhui, China
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhiyuan Hou, PhD
Principal Investigator
Fudan University
Leesa Lin, PhD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported